| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0059 | 0.9 |